Oregon Health & Science University study could one day lead to treatments that prevent or treat diseases and infections linked to a protein found in all human cells.
The protein ubiquitin is transformed during a bacterial infection, according to a study published today in the journal Molecular Cell. The study describes the processes necessary to synthesize lysine 6 polyubiquitin, a type of protein in which a lengthy chain of ubiquitin monomers is linked by the amino acid lysine. This type of ubiquitin aids cell communication by transmitting a chemical message — communication that is still poorly understood.
Previous research has connected this type of ubiquitin to the development of Parkinson’s disease and breast cancer. However, it is unclear how lysine 6 polyubiquitin is generated or how it is related in disease.
To investigate this, OHSU researchers focused on pathogenic bacteria and how they modify lysine 6 polyubiquitin during infection. The researchers extracted enzymes utilized by E. coli and Salmonella to cause food poisoning and other ailments and studied how they interacted with ubiquitin.
The researchers discovered that one specific enzyme was essential for the formation of lysine 6 polyubiquitin.
Previously, the same scientists discovered that a separate enzyme from a different illness-causing bacteria, Legionella pneumophila, which causes a kind of pneumonia known as Legionnaires’ disease, actively tears apart the same molecule during infection.
This means that during infection, various enzymes have varied effects on the same lysine 6 polyubiquitin.
“Knowing how lysine 6 polyubiquitin is regulated is an important first step,” said senior researcher Jonathan Pruneda, Ph.D., an assistant professor of molecular microbiology and immunology at OHSU. “We’ll use this knowledge as a foundation for future research, including looking into how bacteria use ubiquitin to infect cells.”
“One day, I hope we can harness this research to develop new ways to prevent and treat infections and disease.”
Pruneda and colleagues are actively investigating the role of lysine 6 polyubiquitin regulation in Parkinson’s disease and breast cancer.
more recommended stories
Air Pollution Hurts Brain Health in Just 4 HoursAir Pollution Blurs the Mind, Impairs.
New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disordersUrgent treatment solutions are needed for.
three key pillars to tackle antimicrobial resistance effectively — University of Oxford, Medical Sciences DivisionThe High-Level Meeting on antimicrobial resistance.
Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation — University of Oxford, Medical Sciences DivisionThe installation was commissioned to mark.
Professor Ahmed Awarded Funding To Create World’s First Ovarian Cancer Prevention Vaccine — University of Oxford, Medical Sciences DivisionScientists at the University of Oxford,.
New research network unites Oxford University’s global fight against antimicrobial resistance — University of Oxford, Medical Sciences DivisionAntimicrobial resistance (AMR) threatens the foundation.
Typhoid vaccine trial confirms sustained protection for older children — University of Oxford, Medical Sciences DivisionThe TyVOID study, published in the Lancet, measured the.
Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer — University of Oxford, Medical Sciences DivisionThe research addresses the long-recognized poor.
Four Oxford researchers win prestigious Philip Leverhulme Prizes — University of Oxford, Medical Sciences DivisionOnly 30 prizes are awarded throughout.
Kavli Oxford’s Nick Gatford Wins Image of Distinction Award in Nikon Small World Competition — University of Oxford, Medical Sciences DivisionThe Nikon Small World competition, often.
Leave a Comment